Predilife S.A. (EPA:ALPRE)
France · Delayed Price · Currency is EUR 0.8500
0.00 (0.00%)
Oct 15, 2026, 2:24 PM CET
Predilife Company Description
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses.
It provides breast cancer predictive assessment; and multi-pathology predictive assessment. The company also offers MammoRisk, a breast cancer prediction test based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software.
Predilife S.A. was incorporated in 2004 and is headquartered in Villejuif, France.
Predilife S.A.
| Country | France |
| Founded | 2004 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 21 |
| CEO | Stephane Ragusa |
Contact Details
Address: 39 Rue Camille Desmoulins Villejuif, 94805 France | |
| Phone | 33 9 72 22 67 08 |
| Website | predilife.com |
Stock Details
| Ticker Symbol | ALPRE |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0010169920 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Stephane Ragusa | Founder, President, Chief Executive Officer and Chairman |
| Émilien Gauthier | Chief Technical Officer |
| Marion Renelier | Legal Director and Data Protection Officer |
| Anne Kerzan | Chief Marketing Officer |